HOME >> MEDICINE >> NEWS
Over-diagnosis of liver failure after paracetamol poisoning?

Danish authors of a Research letter in this week's issue of THE LANCET suggest that there is the potential for clinicians to mistakingly diagnose liver failure after moderate paracetamol poisoning by relying solely on the measurement of one diagnostic marker.

The use of acetylcysteine after paracetamol poisoning is of known therapeutic benefit; acetylcysteine is an anticoagulant (ie. It increases blood-clotting time) which is associated with a decrease in the prothrombin ratio, a protein involved in blood clotting.

Lars Schmidt from Rigshospitalet University, Copenhagen, and colleagues retrospectively assessed the prothrombin index before and during acetylcysteine treatment in 87 patients with moderate paracetamol poisoning. The prothrombin index decreased by around a third after the initiation of acetylcysteine treatment.

Lars Schmidt comments: "In the management of acute paracetamol poisoning, a fall in coagulation activity is generally thought to be a result of decreased synthesis of clotting factors, which is associated with the development of liver failure. Since the indications for starting acetylcysteine treatment are broad, many patients receive treatment without ever developing signs of hepatocellular injury. Our results show that the decrease in prothrombin index values caused by acetylcysteine can be large and, consequently, could be misinterpreted as a sign of liver failure. Even though the prothrombin index provides useful prognostic information, management decisions should not solely be based on measurement of this value."

In an accompanying Commentary (p 1115), Stanislas Pol and Pascal Lebray from Hpital Necker, Paris, France, conclude: "Physicians have to know that in patients with paracetamol poisoning without liver toxicity an isolated decrease in the prothrombin index may only reflect the interaction between [blood] clotting factors and NAC n-acetylcysteine], and should not be misinterpreted as a predictive factor
'"/>

Contact: Richard Lane
richard.lane@lancet.com
44-207-424-4949
Lancet
10-Oct-2002


Page: 1 2

Related medicine news :

1. Research offers hope of new treatments for liver damage
2. Success of liver transplantation may be most influenced by three risk factors
3. Alcohol relapse adversely affects 10-year liver transplant survival
4. Donor age has no affect on long-term liver transplant survival
5. NHS stop-smoking services are insufficient to deliver national smoking targets
6. New ways to design safer & more effective topical (transdermal) drug delivery announced in the PNAS
7. Component of green tea protects injured livers in mice
8. Biochemical marker aids prognosis in liver transplant patients
9. Radiologists offer non-surgical treatment for early-stage liver cancer
10. Florida Tech scientist wins patent for device to deliver X-ray irradiation
11. Studies examine coffee drinking and risk of liver and colorectal cancers

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:8/31/2020)... ... ... The pandemic and topsy-turvy economic outlook continues to put financial strain on many of us, ... the fat from our monthly expenses and put more into savings, if possible. , “That’s ... a financial safety net in place in case something were to happen to you,” says ...
(Date:8/31/2020)... NEW HAVEN, Conn. (PRWEB) , ... August 31, ... ... a medical device intended to improve outcomes for patients with advanced heart failure, ... Innovation Research (SBIR) grant in the amount of $555,358 from the National Heart, ...
(Date:8/28/2020)... ... August 28, 2020 , ... The ... a customized Lighthouse Health & Wellness mobile app and web-portal. NCPCV received a ... Solutions Foundation awards grants each year to organizations, such as Destination Imagination, which ...
(Date:8/28/2020)... , ... August 28, 2020 , ... ... observations that strongly suggest that obese individuals are at an increased risk of ... any more likely to catch COVID-19; however, because the same organ systems that ...
(Date:8/26/2020)... ... August 26, 2020 , ... Smile ... upcoming Global Inclusion Online Forum, leading a session entitled, “A CEO Guide for ... of this magnitude designed to bring together the world’s leading diversity and inclusion ...
Breaking Medicine News(10 mins):
(Date:9/3/2020)... ... 2020 , ... Q&J Face Masks announced today that the ... engineering lab, conducted tests on Q&J’s personal face mask that indicated the Q&J ... masks. Q&J face masks have both mechanical filtering and electrostatic filtering which are ...
(Date:9/2/2020)... (PRWEB) , ... September 02, 2020 , ... U.S. ... Jonathan Lee . Dr. Lee will work at Bethesda Dermatopathology Lab. ... his B.A. from the University of California, Berkley. He went on to receive his ...
(Date:9/1/2020)... ... ... Breast and ovarian cancers are common diseases that affect many women. According to ... per year) and 10% of ovarian cancers (about 2,000 women per year) result from ... the Women’s Excellence Genetic Testing Program. , Dr. Jonathan Zaidan, MD, FACOG, President of ...
Breaking Medicine Technology:
Cached News: